DIN 02460351 — ILARIS 150 MG
ILARIS is a solution of Canakinumab marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Canakinumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02460351
- Brand name
- ILARIS
- Active ingredient
- Canakinumab
- Strength
- 150 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-1 beta (IL-1β) inhibitor (immunomodulatory agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.